Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

The Multispecies Microbial Cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a Precision Biomarker for Colorectal Cancer Diagnosis

  • Ladra, Susana
  • Poza, Margarita
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Buetas, Elena
  • Trigo Tasende, Noelia
  • Nasser-Ali, Mohammed
  • Rumbo-Feal, Soraya
  • Nión, P.
  • Martin-De Arribas, E.
  • Estévez, Lara
  • Otero Alén, Begoña
  • Noguera, José
  • Concha López, Ángel
  • Pardiñas López, Simón
  • Carda-Diéguez, Miguel
  • Gómez-Randulfe, Igor
  • Martínez-Lago, Nieves
  • Antón-Aparicio, Luis M.
  • Bou, Germán
  • Mira, Alex
  • Vallejo, J. A.
[Abstract] The incidence of colorectal cancer (CRC) has increased worldwide, and early diagnosis is crucial to reduce mortality rates. Therefore, new noninvasive biomarkers for CRC are required. Recent studies have revealed an imbalance in the oral and gut microbiomes of patients with CRC, as well as impaired gut vascular barrier function. In the present study, the microbiomes of saliva, crevicular fluid, feces, and non-neoplastic and tumor intestinal tissue samples of 93 CRC patients and 30 healthy individuals without digestive disorders (non-CRC) were analyzed by 16S rRNA metabarcoding procedures. The data revealed that Parvimonas, Fusobacterium, and Bacteroides fragilis were significantly over-represented in stool samples of CRC patients, whereas Faecalibacterium and Blautia were significantly over-abundant in the non-CRC group. Moreover, the tumor samples were enriched in well-known periodontal anaerobes, including Fusobacterium, Parvimonas, Peptostreptococcus, Porphyromonas, and Prevotella. Co-occurrence patterns of these oral microorganisms were observed in the subgingival pocket and in the tumor tissues of CRC patients, where they also correlated with other gut microbes, such as Hungatella. This study provides new evidence that oral pathobionts, normally located in subgingival pockets, can migrate to the colon and probably aggregate with aerobic bacteria, forming synergistic consortia. Furthermore, we suggest that the group composed of Fusobacterium, Parvimonas, Bacteroides, and Faecalibacterium could be used to design an excellent noninvasive fecal test for the early diagnosis of CRC. The combination of these four genera would significantly improve the reliability of a discriminatory test with respect to others that use a single species as a unique CRC biomarker., The authors want to appreciate the good disposition of all the CRC patients for collaborating with us. We would like to thank Gema Carro Díaz and Montserrat Ingelmo Sánchez for their assistance during patients' recruitment time and also during tissue sample collection. This work would not be possible without the support of professionals from the Microbiology, Surgery, Pathology and Oncology Services and Biobank of CHUAC (Spain). The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the project PI20/00413, cofunded by the European Union (EU) to MP. The whole work has been also supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by CIBER INFEC ISCIII (CB21/13/00055) to GB and MP Biobank of A Coruña was supported by ISCIII-Fondos FEDER (EU) by grant PT20/00128. KC-P was financially supported by the Spanish Association against Cancer (AECC). EB was supported by a grant from the Spanish Ministry of Science and Innovation PRE2019-088126. SL and EM-DA were supported by grants from GAIN (Xunta de Galicia, Spain) with references ED431C 2021/53 and ED431G 2019/01., Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G 2019/01
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Parvimonas Micra Can Translocate From the Subgingival Sulcus of the Human Oral Cavity to Colorectal Adenocarcinoma

  • Conde-Pérez, Kelly
  • Buetas, Elena
  • Aja-Macaya, Pablo
  • Martin-De Arribas, E.
  • Iglesias Corrás, Iago
  • Trigo Tasende, Noelia
  • Nasser-Ali, Mohammed
  • Estévez, Lara
  • Rumbo-Feal, Soraya
  • Otero Alén, Begoña
  • Noguera, José
  • Concha López, Ángel
  • Pardiñas López, Simón
  • Carda-Diéguez, Miguel
  • Gómez-Randulfe, Igor
  • Martínez-Lago, Nieves
  • Ladra, Susana
  • Antón-Aparicio, Luis M.
  • Bou, Germán
  • Mira, Alex
  • Vallejo, J. A.
  • Poza, Margarita
[Abstract] Oral and intestinal samples from a cohort of 93 colorectal cancer (CRC) patients and 30 healthy controls (non-CRC) were collected for microbiome analysis. Saliva (28 non-CRC and 94 CRC), feces (30 non-CRC and 97 CRC), subgingival fluid (20 CRC), and tumor tissue samples (20 CRC) were used for 16S metabarcoding and/or RNA sequencing (RNAseq) approaches. A differential analysis of the abundance, performed with the ANCOM-BC package, adjusting the P-values by the Holm-Bonferroni method, revealed that Parvimonas was significantly over-represented in feces from CRC patients (P-value < 0.001) compared to healthy controls. A total of 11 Parvimonas micra isolates were obtained from the oral cavity and adenocarcinoma of CRC patients. Genome analysis identified a pair of isolates from the same patient that shared 99.2% identity, demonstrating that P. micra can translocate from the subgingival cavity to the gut. The data suggest that P. micra could migrate in a synergistic consortium with other periodontal bacteria. Metatranscriptomics confirmed that oral bacteria were more active in tumor than in non-neoplastic tissues. We suggest that P. micra could be considered as a CRC biomarker detected in non-invasive samples such as feces., This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI20/00413 and co-funded by the European Union to MP. The work has been also supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by the CIBER INF ISCIII (CB21/13/00055) to GB and MP. Biobank of University Hospital Complex of A Coruña was supported by Instituto de Salud Carlos III – Fondos FEDER (EU) by grant PT20/00128. K. Conde-Pérez was financially supported with a predoctoral fellowship by the Asociación Española Contra el Cáncer (AECC). E. Buetas is supported by a grant from the Spanish Ministry of Science and Innovation with the reference PRE2019-088126. S. Ladra, E. Martin-De Arribas and Iago Iglesias-Corrás are supported by grants from GAIN (Xunta de Galicia, Spain) with references ED431C 2021/53 and ED431G, Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G